Bogart Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.04K Hold
16
– – ﹤0.01% 1172
2026
Q2
$4.7K Buy
16
+9
+129% +$2.55K ﹤0.01% 1219
2026
Q1
$1.95K Buy
+7
New +$2.02K ﹤0.01% 1281
2023
Q3
– Sell
-14
Closed -$5.31K – 1074
2023
Q2
$5.31K Hold
14
– – ﹤0.01% 695
2023
Q1
$6.71K Hold
14
– – ﹤0.01% 660
2022
Q4
$5.9K Hold
14
– – ﹤0.01% 635
2022
Q3
$6K Hold
14
– – ﹤0.01% 648
2022
Q2
$7K Buy
14
+1
+8% +$521 ﹤0.01% 584
2022
Q1
$7K Buy
+13
New +$7.84K ﹤0.01% 529

Other funds holding BIO

Bogart Wealth's BIO Position: Q3 2026 in Review

Bogart Wealth held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 16 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Bogart Wealth first reported a position in BIO in Q1 2022 and has held it in 9 quarters since. The position peaked at $7K in Q2 2022. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Bogart Wealth held 16 shares of Bio-Rad Laboratories Class A worth $6.04K as of Q3 2026.
  • Bogart Wealth left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1172 holding.
  • Bogart Wealth first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 9 quarters since.
  • Bogart Wealth's Bio-Rad Laboratories Class A position peaked at $7K in Q2 2022.
  • 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.